Dunes Point Capital, LP Announces the Acquisition of Greenwood Industries, LLC
RYE, N.Y., May 8, 2025 /PRNewswire/ — Dunes Point Capital, LP (“DPC”) has acquired Greenwood Industries, LLC (“Greenwood”). Located... Read more.
AI Observability Market Disruptions: Riding a High-Growth Wave Through 2030 at CAGR 25.47%
Compound Growth at 25.47% Signals a New Phase of AI Observability Market Expansion MIDDLETON, Mass., May 8, 2025 /PRNewswire/ — QKS Group, a premier market... Read more.
Viatris Reports First Quarter 2025 Results and Reaffirms 2025 Outlook
Delivers Total Revenues in Line With Expectations Demonstrating Strength of the Base Business Makes Significant Pipeline Progress With Three Positive Phase 3 Data... Read more.
Q32 Bio Reports First Quarter 2025 Financial Results and Provides Corporate Update
— First patient dosed in SIGNAL-AA Phase 2a Part B; topline data readout on-track for 1H’26 — — First patient dosed in SIGNAL-AA Part A open-label... Read more.
Cogent Communications Reports First Quarter Results and Increases its Regular Quarterly Dividend on its Common Stock
Financial and Business Highlights Service revenue was $247.0 million for Q1 2025 and was $252.3 million for Q4 2024. Revenue from leasing IPv4 addresses increased... Read more.
Forever Labs Announces Spinout of SuperShot Inc. and Appoints New CEO
ANN ARBOR, Mich., May 8, 2025 /PRNewswire/ — Forever Labs, a pioneer in stem cell banking and regenerative medicine, today announced the formal spinout of... Read more.
Viatris Announces Positive Results from Phase 3 Study of Investigational XULANE LO™ Low Dose Patch for Birth Control in Women of Childbearing Potential
Treatment With XULANE LO Low Estrogen Dose Achieved Primary and All Secondary Efficacy and Safety Endpoints Results Demonstrated Potential Best-In-Class Patch Performance ... Read more.
Get Well Appoints Data and AI Industry Leaders to Power AI Roadmap
Experienced executives join to launch new precision care platform BETHESDA, Md., May 8, 2025 /PRNewswire/ — Get Well, the leader in digital patient engagement,... Read more.
Caris Life Sciences Appoints Eric Matthews as Chief Business Officer, Biopharma Business Development
IRVING, Texas, May 8, 2025 /PRNewswire/ — Caris Life Sciences® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer, today... Read more.
Viatris Announces Positive Top-Line Results from Two Pivotal Phase 3 Studies of Novel Fast-Acting Meloxicam (MR-107A-02) for the Treatment of Moderate-to-Severe Acute Pain
All Primary and Secondary Endpoints Were Met in Both Phase 3 Studies In Both Acute Pain Models, MR-107A-02 Demonstrated Statistically Significant and Clinically... Read more.